Richard J. Daly, Director at OPIANT PHARMACEUTICALS, INC. (OPNT), bought 1,800 shares at $13.90 ($25K) on 2019-09-12, disclosed to the SEC on 2020-03-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| BR | SELL | 2024-09-09 | $6.4M | — | Filing → |
| CPRX | SELL | 2024-06-05 | $554K | — | Filing → |
| BR | SELL | 2023-08-29 | $3.1M | — | Filing → |